                         SEQUENCE LISTING

<110>  UCL BUSINESS LTD
 
<120>  PEPTIDE INHIBITORS

<130>  N418499WO

<160>  12    

<170>  PatentIn version 3.5

<210>  1
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  P5 and stapled-P5 consensus amino acid sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  X is either omitted or GQEDYD

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  X is either R or 2,(4, pentenyl)alanine

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  X is either R or 2,(4, pentenyl)alanine

<220>
<221>  MISC_FEATURE
<222>  (12)..(12)
<223>  X is either omitted or DVI

<400>  1

Xaa Arg Leu Xaa Pro Ala Ser Xaa Pro Asp Thr Xaa 
1               5                   10          


<210>  2
<211>  132
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  F1 amino acid sequence

<400>  2

Ser Arg Glu Asp Phe Pro Leu Ile Glu Thr Glu Asp Glu Ala Tyr Leu 
1               5                   10                  15      


Arg Arg Ile Lys Met Glu Leu Gln Gln Lys Asp Lys Ala Leu Val Glu 
            20                  25                  30          


Leu Leu Arg Glu Lys Val Gly Leu Phe Ala Glu Met Thr His Phe Gln 
        35                  40                  45              


Val Glu Glu Asp Ser Gly Gly Val Ala Leu Pro Ala Leu Pro Arg Gly 
    50                  55                  60                  


Leu Phe Arg Ser Glu Ser Leu Glu Cys Pro Arg Gly Glu Arg Leu Leu 
65                  70                  75                  80  


Gln Asp Ala Ile Arg Glu Val Glu Gly Leu Lys Asp Leu Leu Val Gly 
                85                  90                  95      


Pro Gly Val Glu Leu Leu Leu Thr Pro Arg Asp Pro Ala Leu Leu Val 
            100                 105                 110         


Asp Pro Asp Ser Gly Gly Ser Thr Ser Pro Gly Val Thr Ala Asn Gly 
        115                 120                 125             


Glu Ala Arg Asn 
    130         


<210>  3
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  P5 amino acid sequence

<400>  3

Gly Gln Glu Asp Tyr Asp Arg Leu Arg Pro Ala Ser Tyr Pro Asp Thr 
1               5                   10                  15      


Asp Val Ile 
            


<210>  4
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  core TAT amino acid sequence

<400>  4

Arg Lys Lys Arg Arg Gln Arg Arg Arg 
1               5                   


<210>  5
<211>  32
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  TAT-P5 amino acid sequence

<400>  5

Gly Arg Lys Lys Arg Arg Gln Arg Arg Arg Pro Trp Gln Gly Gln Glu 
1               5                   10                  15      


Asp Tyr Asp Arg Leu Arg Pro Ala Ser Tyr Pro Asp Thr Asp Val Ile 
            20                  25                  30          


<210>  6
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  stapled-P5 amino acid sequence


<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  X is 2,(4, pentenyl)alanine

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  X is 2,(4, pentenyl)alanine

<400>  6

Arg Leu Xaa Pro Ala Ser Xaa Pro Asp Thr 
1               5                   10  


<210>  7
<211>  164
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  TAT-F1 amino acid sequence

<400>  7

Met Gly Gly Tyr Gly Arg Lys Lys Arg Arg Gln Arg Arg Arg Gly Gly 
1               5                   10                  15      


Gly Ser Gly Tyr Pro Tyr Asp Val Pro Asp Tyr Ala Gly Gly Ser Ser 
            20                  25                  30          


Ser Arg Glu Asp Phe Pro Leu Ile Glu Thr Glu Asp Glu Ala Tyr Leu 
        35                  40                  45              


Arg Arg Ile Lys Met Glu Leu Gln Gln Lys Asp Lys Ala Leu Val Glu 
    50                  55                  60                  


Leu Leu Arg Glu Lys Val Gly Leu Phe Ala Glu Met Thr His Phe Gln 
65                  70                  75                  80  


Val Glu Glu Asp Ser Gly Gly Val Ala Leu Pro Ala Leu Pro Arg Gly 
                85                  90                  95      


Leu Phe Arg Ser Glu Ser Leu Glu Cys Pro Arg Gly Glu Arg Leu Leu 
            100                 105                 110         


Gln Asp Ala Ile Arg Glu Val Glu Gly Leu Lys Asp Leu Leu Val Gly 
        115                 120                 125             


Pro Gly Val Glu Leu Leu Leu Thr Pro Arg Asp Pro Ala Leu Leu Val 
    130                 135                 140                 


Asp Pro Asp Ser Gly Gly Ser Thr Ser Pro Gly Val Thr Ala Asn Gly 
145                 150                 155                 160 


Glu Ala Arg Asn 
                


<210>  8
<211>  32
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  TAT-scrambled P5 amino acid sequence

<400>  8

Gly Arg Lys Lys Arg Arg Gln Arg Arg Arg Pro Trp Gln Asp Tyr Ile 
1               5                   10                  15      


Ala Glu Val Pro Arg Ser Asp Tyr Asp Leu Arg Pro Thr Gly Gln Asp 
            20                  25                  30          


<210>  9
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  VSV amino acid sequence

<400>  9

Thr Asp Ile Glu Met Asn Arg Leu Gly Lys 
1               5                   10  


<210>  10
<211>  396
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  F1 nucleotide sequence

<400>  10
tccagggagg acttccccct gattgagaca gaggatgagg cttacctgcg gcgaattaag       60

atggagttgc agcagaagga ccgggcactg tggagctgct gcgagagaag tcggctgttc      120

gctaagatga cccatttcca ggccgaagag gctggtggca gtgggctggc cctgcccacc      180

atgcccaggg gccttttccg ctctgagtcc cttgagtccc ctcgtggcga gcggctgctg      240

caggatgcca tccgtgaggt ggagggtctg aaagacctgc tggtggggcc aggagtggaa      300

ctgctcttga caccccgaga gccagccctg cccttggaac cagacagcgg tggtaacacg      360

agtcctgggg tcactgccaa tggtgaggcc agaaat                                396


<210>  11
<211>  57
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  P5 nucleotide sequence

<400>  11
ggccaggagg actacgacag gctgaggccc gccagctacc ccgacaccga cgtgatc          57


<210>  12
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  amino acid sequence

<400>  12

Gly Gln Glu Asp Tyr Asp 
1               5       


